Targeting IGF1R signaling for brain aging and Alzheimer’s disease

The role of IGF1R signaling in the brain and its relationship to aging and neurological dysfunction is controversial. Because it was shown that low IGF1R activity consistently improved myocardial bioenergetics and function in hearts from aging mice, but not hearts from young mice, it was of interest to investigate this relationship in brain aging. We used CRISPR technology to develop a mouse model with targeted replacement of mouse IGF1R with the equivalent of the human R407H (IGF1RR407H) variant enriched in centenarians with a reduction in IGF1R protein activity. Middle-aged mice show improved cognitive performance thus possibly modeling IGF1R signaling in the aging brain, similar to what was reported in the aging heart. Because Alzheimer’s disease (AD) is an age-related disease, specific IGF1RR407H pathways could be therapeutic targets in mice with AAV vector-based AD as well as for overall brain aging.

[1]  Youshuo Liu,et al.  Accelerated aging-related transcriptome alterations in neurovascular unit cells in the brain of Alzheimer’s disease , 2022, Frontiers in Aging Neuroscience.

[2]  G. Kroemer,et al.  Spermidine overrides INSR (insulin receptor)-IGF1R (insulin-like growth factor 1 receptor)-mediated inhibition of autophagy in the aging heart , 2022, Autophagy.

[3]  Kenny Q. Ye,et al.  The antagonistic pleiotropy of insulin‐like growth factor 1 , 2021, Aging cell.

[4]  M. Klug,et al.  IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model , 2020, Frontiers in Cellular Neuroscience.

[5]  R. Holtzer,et al.  Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults , 2020, Cells.

[6]  M. Darvas,et al.  Development of an IGF1R longevity variant mouse line using CRISPR/Cas9 genome editing , 2020, Trends in biomedical research.

[7]  M. Darvas,et al.  A geroscience mouse model for Alzheimer’s disease , 2019, Pathobiology of aging & age related diseases.

[8]  D. Allison,et al.  Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice , 2018, Nature Communications.

[9]  W. Freeman,et al.  Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes , 2018, Molecular metabolism.

[10]  M. Holzenberger,et al.  The Alzheimer’s disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons , 2017, Brain : a journal of neurology.

[11]  Ying Ann Chiao,et al.  The Aging Heart. , 2015, Cold Spring Harbor perspectives in medicine.

[12]  N. Barzilai,et al.  Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span. , 2015, Cold Spring Harbor perspectives in medicine.

[13]  N. Barzilai,et al.  Impaired IGF1R signaling in cells expressing longevity‐associated human IGF1R alleles , 2011, Aging cell.

[14]  C. Kenyon.  The genetics of ageing , 2010, Nature.